Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors

Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium–glucose co-transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic drugs with cardiovascular benefits beyond other antidiabetic drugs. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahnwong, Sarayut, Chattipakorn, Siriporn C., Chattipakorn, Nipon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038192/
https://www.ncbi.nlm.nih.gov/pubmed/29991346
http://dx.doi.org/10.1186/s12933-018-0745-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038192/
https://www.ncbi.nlm.nih.gov/pubmed/29991346
http://dx.doi.org/10.1186/s12933-018-0745-5

Ejemplares similares